Paloma Partners’s Cano Health, Inc. CANO Stock Holding History

Paloma Partners’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-797	Closed	-$506K	–	1896
2022 Q1	$506K	Sell	797 -262	-25%	-$165K	0.01%	745
2021 Q4	$944K	Buy	1,059 +838	+379%	+$880K	0.01%	752
2021 Q3	$280K	Buy	+221	New	+$268K	0.01%	748

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Paloma Partners's CANO Position: Q2 2022 in Review

Paloma Partners sold out of Cano Health, Inc. (CANO) in Q2 2022, closing a stake of 797 shares — an estimated $506K sold.

Paloma Partners first reported a position in CANO in Q3 2021 and held it in 3 quarters. The position peaked at $944K in Q4 2021. 144 funds tracked by Wall St. Rank hold CANO as of Q2 2022.

Paloma Partners reported no remaining Cano Health, Inc. position as of Q2 2022 after selling out during the quarter.
Paloma Partners sold 797 Cano Health, Inc. shares in Q2 2022, an estimated $506K.
Paloma Partners first reported a position in Cano Health, Inc. in Q3 2021 and held it in 3 quarters.
Paloma Partners's Cano Health, Inc. position peaked at $944K in Q4 2021.
144 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.